Tag: Keytruda
Merck and co inc: New indication approved for Keytruda in Europe
Receive the value of the day for free every morning The data collected is essential for this processing and is intended for the relevant services of BFM Bourse and, where…
Merck and co inc: Failure of a phase III trial on Keytruda + Lynparza
Receive the value of the day for free every morning The data collected is essential for this processing and is intended for the relevant services of BFM Bourse and, where…
Merck: favorable opinion from the CHMP for Keytruda in NSCLC
(CercleFinance.com) – Merck announced today that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency has given a positive opinion recommending the approval of Keytruda…
Merck and co inc: New approval for Keytruda in Canada
Receive the value of the day for free every morning The data collected is essential for this processing and is intended for the relevant services of BFM Bourse and, where…
Merck: Keytruda partially convinces in urothelial cancer
(CercleFinance.com) – Merck today presents results from a phase III trial evaluating Keytruda as adjuvant treatment for patients with localized muscle invasive urothelial carcinoma (MIUC) and locally advanced resectable urothelial…
Merck and co inc: Keytruda partially convinces in urothelial cancer
Read also (CercleFinance.com) – Merck today presents results from a phase III trial evaluating Keytruda as adjuvant treatment for patients with localized muscle invasive urothelial carcinoma (MIUC) and locally advanced…
Merck and Moderna: new trial of Keytruda against lung cancer – 11/12/2023 at 2:50 p.m.
(AOF) – Merck and Moderna announce the launch of INTerpath-002, a phase 3 study evaluating V940 (mRNA-4157) in combination with Keytruda (pembrolizumab), Merck’s lead product, for the adjuvant treatment of…
Merck: positive trial on Keytruda for perioperative use
(CercleFinance.com) – Merck today announced the results of a phase 3 trial (KEYNOTE-671) evaluating Keytruda as a perioperative treatment regimen, i.e. before surgery (neoadjuvant) and after surgery (adjuvant), for patients…
Merck: promises of Keytruda in gastric cancers
(CercleFinance.com) – Merck today announced the results of the phase 3 trial (KEYNOTE-811) evaluating Keytruda in combination with trastuzumab, fluoropyrimidine and platinum chemotherapy, for the first-line treatment of patients with…
Merck: failure of Keytruda against lung cancer – 09/22/2023 at 2:45 p.m.
(AOF) – The American laboratory Merck and its Japanese partner Eisai declared this Friday that a combination of their anticancer therapies failed to prolong the lives of patients in two…
Merck and co inc: Positive opinion from the CHMP for Keytruda
Receive the value of the day for free every morning The data collected is essential for this processing and is intended for the relevant services of BFM Bourse and, where…
Merck: positive opinion from the CHMP for Keytruda
(CercleFinance.com) – Merck announced today that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency has issued a positive opinion recommending the approval of Keytruda,…